CC BY-NC-ND 4.0 · Horm Metab Res 2021; 53(05): 326-334
DOI: 10.1055/a-1440-0278
Endocrine Care

Adrenal Hormone Interactions and Metabolism: A Single Sample Multi-Omics Approach

1   Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany
2   Department of Medicine III, Technische Universität Dresden, Dresden, Germany
3   German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Experimental Diabetology, Nuthetal, Germany
4   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
,
Deepika Watts
1   Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany
,
2   Department of Medicine III, Technische Universität Dresden, Dresden, Germany
,
Paal William Wallace
1   Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany
,
Annette Schürmann
3   German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Experimental Diabetology, Nuthetal, Germany
4   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
,
Stefan R. Bornstein
2   Department of Medicine III, Technische Universität Dresden, Dresden, Germany
,
Ben Wielockx
1   Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany
,
Graeme Eisenhofer
1   Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany
2   Department of Medicine III, Technische Universität Dresden, Dresden, Germany
,
Mirko Peitzsch
1   Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany
› Author Affiliations
Funding Deutsche Forschungsgemeinschaft (DFG) CRC/Transregio 205/1 (Project No. 314061271), INST 515/28–1 FUGG and German Ministry of Education and Research and the Brandenburg State 82DZD00302.

Abstract

The adrenal gland is important for many physiological and pathophysiological processes, but studies are often restricted by limited availability of sample material. Improved methods for sample preparation are needed to facilitate analyses of multiple classes of adrenal metabolites and macromolecules in a single sample. A procedure was developed for preparation of chromaffin cells, mouse adrenals, and human chromaffin tumors that allows for multi-omics analyses of different metabolites and preservation of native proteins. To evaluate the new procedure, aliquots of samples were also prepared using conventional procedures. Metabolites were analyzed by liquid-chromatography with mass spectrometry or electrochemical detection. Metabolite contents of chromaffin cells and tissues analyzed with the new procedure were similar or even higher than with conventional methods. Catecholamine contents were comparable between both procedures. The TCA cycle metabolites, cis-aconitate, isocitate, and α-ketoglutarate were detected at higher concentrations in cells, while in tumor tissue only isocitrate and potentially fumarate were measured at higher contents. In contrast, in a broad untargeted metabolomics approach, a methanol-based preparation procedure of adrenals led to a 1.3-fold higher number of detected metabolites. The established procedure also allows for simultaneous investigation of adrenal hormones and related enzyme activities as well as proteins within a single sample. This novel multi-omics approach not only minimizes the amount of sample required and overcomes problems associated with tissue heterogeneity, but also provides a more complete picture of adrenal function and intra-adrenal interactions than previously possible.

Supplementary Material



Publication History

Received: 11 January 2021

Accepted after revision: 11 March 2021

Article published online:
26 April 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Goldstein DS. Adrenal responses to stress. Cell Mol Neurobiol 2010; 30: 1433-1440
  • 2 Berger I, Werdermann M, Bornstein SR. et al. The adrenal gland in stress–Adaptation on a cellular level. J Steroid Biochem Mol Biol 2019; 190: 198-206
  • 3 Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32: 81-151
  • 4 Bornstein SR, Berger I, Scriba L. et al. Adrenal cortex–medulla interactions in adaptation to stress and disease. Curr Opin Endocr Metab Res 2019; 8: 9-14
  • 5 Qin N, Peitzsch M, Menschikowski M. et al. Double stable isotope ultra performance liquid chromatographic-tandem mass spectrometric quantification of tissue content and activity of phenylethanolamine N-methyltransferase, the crucial enzyme responsible for synthesis of epinephrine. Anal Bioanal Chem 2013; 405: 1713-1719
  • 6 Wurtman RJ, Axelrod J. Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids. Science 1965; 150: 1464-1465
  • 7 Ehrhart-Bornstein M, Bornstein SR, Güse-Behling H. et al. Sympathoadrenal regulation of adrenal androstenedione release. Neuroendocrinol 1994; 59: 406-412
  • 8 Ehrhart-Bornstein M, Hilbers U. Neuroendocrine properties of adrenocortical cells. Horm Metab Res 1998; 30: 436-439
  • 9 Lefebvre H, Prevost G, Louiset E. Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism. Eur J Endocrinol 2013; 169: R115-R138
  • 10 Constantinescu G, Langton K, Conrad C. et al. Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension. J Clin Endocrinol Metab 2020; 105: e3374-e3383
  • 11 Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335: 1206-1212
  • 12 Eisenhofer G, Lenders JW, Goldstein DS. et al. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 2005; 51: 735-744
  • 13 Richter S, Peitzsch M, Rapizzi E. et al. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. J Clin Endocrinol Metab 2014; 99: 3903-3911
  • 14 Surowiec I, Koc M, Antti H. et al. LC-MS/MS profiling for detection of endogenous steroids and prostaglandins in tissue samples. J Sep Sci 2011; 34: 2650-2658
  • 15 Eisenhofer G, Goldstein DS, Stull R. et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986; 32: 2030-2033
  • 16 Bechmann N, Poser I, Seifert V. et al. Impact of extrinsic and intrinsic hypoxia on catecholamine biosynthesis in absence or presence of HIF2α in pheochromocytoma cells. Cancers 2019; 11: 594
  • 17 Peitzsch M, Dekkers T, Haase M. et al. An LC–MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. J Steroid Biochem Mol Biol 2015; 145: 75-84
  • 18 Richter S, Gieldon L, Pang Y. et al. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma. Genet Med 2019; 21: 705-717
  • 19 Wishart DS, Feunang YD, Marcu A. et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 2017; 46(D1): D608-D617
  • 20 Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30
  • 21 Bechmann N, Ehrlich H, Eisenhofer G. et al. Anti-tumorigenic and anti-metastatic activity of the sponge-derived marine drugs aeroplysinin-1 and isofistularin-3 against pheochromocytoma in vitro. Mar Drugs 2018; 16: 172
  • 22 Fishbein L, Leshchiner I, Walter V. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 2017; 31: 181-193 DOI: 10.1016/j.ccell.2017.01.001.
  • 23 Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest 2013; 123: 3685-3692
  • 24 Eisenhofer G, Lenders JW, Siegert G. et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer 2012; 48: 1739-1749
  • 25 Bechmann N, Moskopp ML, Ullrich M. et al. HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. Endocr Relat Cancer 2020; 27: 625-640
  • 26 Eisenhofer G, Pacak K, Huynh T-T. et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer 2011; 18: 97-111
  • 27 Bi H, Krausz KW, Manna SK. et al. Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells. Anal Bioanal Chem 2013; 405: 5279-5289
  • 28 Dietmair S, Timmins NE, Gray PP. et al. Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol. Anal Biochem 2010; 404: 155-164